Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 24;2(1):100034.
doi: 10.1016/j.bvth.2024.100034. eCollection 2025 Feb.

Podoplanin and microthrombi in lung injury

Affiliations

Podoplanin and microthrombi in lung injury

Jahnavi Gollamudi et al. Blood Vessel Thromb Hemost. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
PDPN plasma level in patients with COVID-19. PDPN plasma levels and the severity of COVID-19 as defined by the National Institutes of Health criteria.
Figure 2.
Figure 2.
Expression of PDPN in the lung in COVID-19 pneumonia. Tissue specimens from the lungs of patients with COVID-19 pneumonia and patients without COVID-19 obtained during autopsy were examined. (A) Hematoxylin and eosin (H&E) and (B) immunohistochemistry stain for PDPN of the non–COVID-19 lung. Immunofluorescence staining of non–COVID-19 lungs with (C) lower original magnification (×100) and (D) higher original magnification (×200) showing few platelets in the lung parenchyma inside blood vessels (white arrowheads). (E) H&E and (F) immunohistochemistry stain for PDPN of COVID-19 lungs. Immunofluorescence staining of COVID-19 lungs at (G) lower original magnification (×100) and (H′-H′′) higher original magnification (×200). Platelets inside blood vessels are indicated with white arrowheads, and those colocalized with PDPN with yellow arrowheads. (I) Expressions of PDPN in COVID-19 and non–COVID-19 lungs are compared as mean fluorescence intensity (MFI) of immunofluorescence-stained slides. The box and whisker graph shows minimum to maximum values in each group (non–COVID-19: 182.5 ± 24.8, COVID-19: 261.7 ± 7.42; n = 4 images per group; P = .02, unpaired t test).

Similar articles

References

    1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. - PMC - PubMed
    1. McGonagle D, Sharif K, O'Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6) - PMC - PubMed
    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–2040. - PMC - PubMed
    1. Mohamed MFH, Al-Shokri SD, Shunnar KM, et al. Prevalence of venous thromboembolism in critically ill COVID-19 patients: systematic review and meta-analysis. Front Cardiovasc Med. 2020;7 - PMC - PubMed
    1. Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152–160. - PMC - PubMed

LinkOut - more resources